This site is intended for healthcare professionals
News

Phase III REFALS trial of Simdax fails to meet endpoints in amyotrophic lateral sclerosis.- Orion

Read time: 1 mins
Last updated:29th Jul 2020
Published:29th Jul 2020
Condition: Amyotrophic Lateral Sclerosis
Type: drug
Register free for full access to medthority.com